StoxDivi's Laboratories vs Laurus Labs: share price & financials comparison
NSE: DIVISLAB vs LAURUSLABS · Healthcare · as of 06 Nov 2026
Both prices rebased to 100 at the start of the selected period.
Divi's Laboratories vs Laurus Labs at a glance
Divi's Laboratories (DIVISLAB) has a market capitalisation of ₹2,73,493 Cr, against ₹1,26,430 Cr for Laurus Labs (LAURUSLABS). Over the past year Laurus Labs has returned +143.3%, compared with +58.5% for Divi's Laboratories. On valuation, Divi's Laboratories trades at a lower P/E of 93.5 versus 94.4. Laurus Labs earns a higher return on equity (22.1% vs 17.5%). Divi's Laboratories comes out ahead on size, valuation and profitability. Laurus Labs comes out ahead on growth, momentum and technicals. Across the scored metrics below, Divi's Laboratories leads on 8 and Laurus Labs on 8. On StoxGud's 10-point checklist, Divi's Laboratories scores 8/10 and Laurus Labs scores 8/10.
| Metric | Divi's Laboratories | Laurus Labs |
|---|---|---|
| Size | ||
| Market cap | ₹2,73,493 Cr | ₹1,26,430 Cr |
| Revenue (latest FY) | ₹10,560 Cr | ₹6,813 Cr |
| Net profit (latest FY) | ₹2,568 Cr | ₹889 Cr |
| Valuation | ||
| P/E | 93.5 | 94.4 |
| P/B | 16.32 | 20.86 |
| Dividend yield | 0.29% | 0.07% |
| Profitability | ||
| Return on equity | 17.5% | 22.1% |
| Net profit margin | 26.0% | 17.1% |
| Operating margin | 35.3% | 30.4% |
| Growth | ||
| Revenue growth (YoY) | +27.8% | +33.4% |
| Net profit growth (YoY) | +65.5% | +126.4% |
| Revenue CAGR (multi-year) | +11.8% | +7.2% |
| Financial health | ||
| Debt to equity | 0.00 | 0.41 |
| Momentum | ||
| 1-month return | +7.6% | +14.0% |
| 1-year return | +58.5% | +143.3% |
| 3-year CAGR | +43.3% | +84.5% |
| 5-year CAGR | +16.1% | +36.4% |
| 10-year CAGR | +23.3% | — |
| Distance from 52W high | +0.0% | -2.7% |
| Technicals | ||
| RSI (14) | 82 | 71 |
| Price vs 200-day avg | +39.4% | +58.0% |
Highlighted cells lead on that metric. Market cap, revenue and RSI are shown for context and not scored.
10-point checklist side by side
| Check | Divi's Laboratories | Laurus Labs |
|---|---|---|
| Price above 50-day average | ✓ | ✓ |
| Price above 200-day average | ✓ | ✓ |
| 50-day average above 200-day (uptrend) | ✓ | ✓ |
| RSI in healthy 40–70 zone | ✗ | ✗ |
| Positive 1-year return | ✓ | ✓ |
| Return on equity above 15% | ✓ | ✓ |
| Debt to equity below 1 | ✓ | ✓ |
| Revenue growing year on year | ✓ | ✓ |
| Net profit margin above 10% | ✓ | ✓ |
| P/E below industry median | ✗ | ✗ |
| Score | 8/10 | 8/10 |
A rules-based screen for education only — not a buy or sell recommendation.
FAQs
Which is bigger, Divi's Laboratories or Laurus Labs?
Divi's Laboratories has a market cap of ₹2,73,493 Cr and Laurus Labs has a market cap of ₹1,26,430 Cr as of 06 Nov 2026.
Which has a lower P/E, Divi's Laboratories or Laurus Labs?
Divi's Laboratories has the lower P/E: Divi's Laboratories trades at 93.5 and Laurus Labs at 94.4.
Which gave better returns in the last year, Divi's Laboratories or Laurus Labs?
Laurus Labs did better: Divi's Laboratories returned +58.5% and Laurus Labs returned +143.3% over one year.
Is Divi's Laboratories or Laurus Labs a better buy?
StoxGud does not give buy or sell recommendations. On our rules-based checklist Divi's Laboratories scores 8/10 and Laurus Labs scores 8/10; compare valuation, profitability, growth and momentum above and consult a SEBI-registered adviser.